Recent FDA Approvals in Leukemia and Lymphoma

This week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.

Coverage of stories discussed this week on ascopost.com:

FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML

FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma

To listen to more podcasts from ASCO, visit asco.org/podcasts.

"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.

This week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.

Coverage of stories discussed this week on ascopost.com:

FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML

FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma

To listen to more podcasts from ASCO, visit asco.org/podcasts.

"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> Coverage of stories discussed this week on ascopost.com:

This week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.

Coverage of stories discussed this week on ascopost.com:

FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML

FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma

To listen to more podcasts from ASCO, visit asco.org/podcasts.

"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML

This week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.

Coverage of stories discussed this week on ascopost.com:

FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML

FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma

To listen to more podcasts from ASCO, visit asco.org/podcasts.

"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma